关注
Valliappan Muthu
Valliappan Muthu
Department of Pulmonary Medicine, PGIMER
在 indiachest.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
Coronavirus disease (Covid-19) associated mucormycosis (CAM): case report and systematic review of literature
D Garg, V Muthu, IS Sehgal, R Ramachandran, H Kaur, A Bhalla, GD Puri, ...
Mycopathologia 186 (2), 289-298, 2021
6442021
Multicenter epidemiologic study of Coronavirus disease–associated mucormycosis, India
A Patel, R Agarwal, SM Rudramurthy, M Shevkani, I Xess, R Sharma, ...
Emerging infectious diseases 27 (9), 2349, 2021
4652021
A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India
A Patel, H Kaur, I Xess, JS Michael, J Savio, S Rudramurthy, R Singh, ...
Clinical Microbiology and Infection 26 (7), 944. e9-944. e15, 2020
4222020
Epidemiology and pathophysiology of COVID-19-associated mucormycosis: India versus the rest of the world
V Muthu, SM Rudramurthy, A Chakrabarti, R Agarwal
Mycopathologia 186 (6), 739-754, 2021
2232021
ECMM/ISHAM recommendations for clinical management of COVID‐19 associated mucormycosis in low‐and middle‐income countries
SM Rudramurthy, M Hoenigl, JF Meis, OA Cornely, V Muthu, ...
Mycoses 64 (9), 1028-1037, 2021
1982021
Guidelines for diagnosis and management of bronchial asthma: Joint ICS/NCCP (I) recommendations
R Agarwal, S Dhooria, AN Aggarwal, VN Maturu, IS Sehgal, V Muthu, ...
Lung India: official organ of Indian Chest Society 32 (Suppl 1), S3, 2015
1222015
Allergic bronchopulmonary aspergillosis
R Agarwal, IS Sehgal, S Dhooria, V Muthu, KT Prasad, A Bal, ...
The Indian Journal of Medical Research 151 (6), 529, 2020
1092020
Has the mortality from pulmonary mucormycosis changed over time? A systematic review and meta-analysis
V Muthu, R Agarwal, S Dhooria, IS Sehgal, KT Prasad, AN Aggarwal, ...
Clinical Microbiology and Infection 27 (4), 538-549, 2021
942021
Allergic Bronchopulmonary Aspergillosis
R Agarwal, V Muthu, IS Sehgal, S Dhooria, KT Prasad, AN Aggarwal
Clinics in Chest Medicine 43 (1), 99-125, 2022
722022
Which are the optimal criteria for the diagnosis of allergic bronchopulmonary aspergillosis? A latent class analysis
P Saxena, H Choudhary, V Muthu, IS Sehgal, S Dhooria, KT Prasad, ...
The Journal of Allergy and Clinical Immunology: In Practice 9 (1), 328-335. e1, 2021
672021
Active pulmonary tuberculosis and coronavirus disease 2019: A systematic review and meta-analysis
AN Aggarwal, R Agarwal, S Dhooria, KT Prasad, IS Sehgal, V Muthu
PloS one 16 (10), e0259006, 2021
632021
High-dose versus low-dose prednisolone in symptomatic patients with post-COVID-19 diffuse parenchymal lung abnormalities: an open-label, randomised trial (the COLDSTER trial)
S Dhooria, S Chaudhary, IS Sehgal, R Agarwal, S Arora, M Garg, ...
European Respiratory Journal 59 (2), 2022
622022
Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and Academy of Pulmonary …
V Muthu, R Agarwal, A Patel, S Kathirvel, OC Abraham, AN Aggarwal, ...
The Lancet Infectious Diseases 22 (9), e240-e253, 2022
592022
Transforming a general hospital to an infectious disease hospital for COVID-19 over 2 weeks
N Pandey, V Kaushal, GD Puri, S Taneja, M Biswal, P Mahajan, RR Guru, ...
Frontiers in public health 8, 382, 2020
592020
Utility of recombinant Aspergillus fumigatus antigens in the diagnosis of allergic bronchopulmonary aspergillosis: A systematic review and diagnostic test accuracy …
V Muthu, IS Sehgal, S Dhooria, AN Aggarwal, R Agarwal
Clinical & Experimental Allergy 48 (9), 1107-1136, 2018
582018
A randomised trial of prednisolone versus prednisolone and itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma
R Agarwal, V Muthu, IS Sehgal, S Dhooria, KT Prasad, M Garg, ...
European Respiratory Journal 59 (4), 2022
522022
Diagnostic cutoffs and clinical utility of recombinant Aspergillus fumigatus antigens in the diagnosis of allergic bronchopulmonary aspergillosis
V Muthu, P Singh, H Choudhary, IS Sehgal, S Dhooria, KT Prasad, ...
The Journal of Allergy and Clinical Immunology: In Practice 8 (2), 579-587, 2020
512020
Multicenter Case-Control Study of COVID-19-Associated Mucormycosis Outbreak, India.
V Muthu, R Agarwal, SM Rudramurthy, D Thangaraju, MR Shevkani, ...
Emerging Infectious Diseases 29 (1), 2023
452023
Efficacy of 12-months oral itraconazole versus 6-months oral itraconazole to prevent relapses of chronic pulmonary aspergillosis: an open-label, randomised controlled trial in …
IS Sehgal, S Dhooria, V Muthu, KT Prasad, AN Aggarwal, A Chakrabarti, ...
The Lancet Infectious Diseases 22 (7), 1052-1061, 2022
452022
CT Findings of COVID-19–associated pulmonary mucormycosis: a case series and literature review
M Garg, N Prabhakar, V Muthu, S Farookh, H Kaur, V Suri, R Agarwal
Radiology 302 (1), 214-217, 2022
442022
系统目前无法执行此操作,请稍后再试。
文章 1–20